Vetter Breaks Ground on $285M Des Plaines Clinical Manufacturing Facility

• Vetter has commenced construction of a new $285 million clinical manufacturing facility in Des Plaines, Illinois.

• The site is expected to be operational for media fill by the end of 2029 and expands Vetter’s clinical network in the U.S. and Europe.

Vetter, a contract development and manufacturing organisation (CDMO), has officially broken ground on a new clinical manufacturing site in Des Plaines, Illinois. The $285 million investment will support small-batch production for early-stage development and expand the company’s capacity to handle novel active ingredients.

The site will include warehouses, laboratories, and administrative offices. With a footprint of approximately 860,000 square feet, the facility also allows for future expansion depending on global demand and strategic investments. Construction is expected to enable media fill operations by the end of 2029.

Located near its existing clinical manufacturing site in Skokie, Illinois, the new facility strengthens Vetter’s North American presence. It also complements the company’s European operations, including its site in Rankweil, Austria.

“This project marks another milestone in our international growth strategy,” said Senator h.c. Udo J. Vetter, Chairman of the Advisory Board. “It underscores our commitment to quality and innovation, as well as our responsibility to our customers, partners, and patients around the world.”